CI

At a glance

ClinicalIndex Comparison Record
Early Ph 1Completed· 120 enrolled
Drug / intervention
Insulindrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00993057
NCT00993057Early Ph 1Completed
CompareCT.gov

Comparing Two Glucose Sampling Frequencies for an Intensive Insulin Protocol During Craniotomy in Non-Diabetic Patients-How Efficiently and Safely Can We Maintain Target Glucose Levels

Northwestern University·interventional·Posted Oct 9, 2009·Updated Dec 13, 2019

In Brief

A Early Phase 1 clinical trial evaluating Insulin for Brain Neoplasms and Intracranial Aneurysm. Completed, enrolled 120 participants across 1 site.

Detailed Summary

What is the efficacy and safety of q 30 minutes vs. q 1hour glucose sampling and intervention for an intensive insulin protocol to achieve and maintain euglycemia in non-diabetic patients undergoing craniotomy? The investigators hypothesize that in non-diabetic patients undergoing craniotomy, monitoring glucose and modifying insulin infusions every 30 minutes compared to every hour will help them reach target glucose levels faster and maintain them more efficiently with the same insulin protocol.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBrain Neoplasms, Intracranial Aneurysm
CountriesUnited States
Collaborators--

Timeline

Early Ph 1CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedOct 9, 2009
Enrollment StartOct 1, 2009
Primary CompletionAug 1, 2012
TodayJul 2, 2026
Enrollment to primary: 2.8 yearsPosted 16.7 years ago

Interventions

Insulindrug

Adjustable insulin infusion scale with loading doses